CVS Health Corp on Wednesday forecast a 2023 profit below Wall Street estimates and said it hoped to mitigate the hit from a performance rating decline for its most popular Medicare plan by encouraging members to shift to other plans.
is expected to reduce 2024 revenue by $2 billion, although that figure could come down with company mitigation strategies.
The diversified healthcare company also disclosed that it is considering selling its Omnicare long-term care business, after last month announcing it will sell its bswift insurance software developer.CVS said it will repurchase shares to meet the 2024 earnings target it set last year, and that it is still open to acquisitions in healthcare services. Lynch described the company as looking for "the right capabilities at the right time.
CVS forecast adjusted 2023 earnings of $8.70 to $8.90 per share, below Wall Street expectations of $9.06, according to Refinitiv data. "While financial engineering is not the strongest way to meet its previously laid out plans, CVS shareholders will likely appreciate that double-digit earnings growth ... is still possible in 2024 and beyond," Morningstar analyst Julie Utterback said in a note.
CVS raised its 2022 profit forecast to $8.55 to $8.65 per share from it prior outlook of $8.40 to $8.60 on the strong performance of its health insurance and PBM business.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
CVS Health agrees to $5B settlement of opioid lawsuitsCVS Health has announced an agreement in principle that would make it the first major pharmacy chain to reach a nationwide settlement of lawsuits over how it handled prescriptions for powerful and addictive prescription opioid painkillers that are linked to an overdose epidemic. The Woonsocket, Rhode Island company would pay about $5 billion over 10 years under a deal that, if accepted, would be one of the largest settlements over the crisis. Other pharmacies, including Rite Aid, Walgreens and Walmart have reached agreements with individual states.
Les mer »
CVS Health agrees to $5B settlement of opioid lawsuitsCVS Health says it has reached a deal that would make it the first major pharmacy chain to settle opioid lawsuits across the United States.
Les mer »
CVS Health agrees to $5B settlement of opioid lawsuitsCVS Health has announced an agreement in principle that would make it the first major pharmacy chain to reach a nationwide settlement of lawsuits over how it handled prescriptions for powerful and addictive prescription opioid painkillers...
Les mer »
CVS Health agrees to $5B settlement of opioid lawsuitsOther pharmacies, including Rite Aid, Walgreens and Walmart have reached agreements with individual states.
Les mer »
CVS Health agrees to $5B settlement of opioid lawsuitsCVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids.
Les mer »
CVS Health agrees to $5B settlement of opioid lawsuitsThe Woonsocket, Rhode Island, company would pay about $5 billion over 10 years under a deal that, if accepted, would be one of the largest settlements over the crisis.
Les mer »